Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2018

Aug 08, 2018

SELL
$71.53 - $95.75 $1.34 Million - $1.79 Million
-18,675 Closed
0 $0
Q1 2018

May 15, 2018

SELL
$60.72 - $74.41 $1.16 Million - $1.42 Million
-19,125 Reduced 50.6%
18,675 $1.37 Million
Q4 2017

Feb 08, 2018

BUY
$44.96 - $58.99 $26,976 - $35,394
600 Added 1.61%
37,800 $2.2 Million
Q3 2017

Nov 02, 2017

SELL
$40.38 - $44.87 $71,674 - $79,644
-1,775 Reduced 4.55%
37,200 $1.67 Million
Q2 2017

May 14, 2018

SELL
N/A
-12,225 Reduced 23.88%
38,975 $1.54 Million
Q1 2017

May 14, 2018

BUY
N/A
4,795 Added 10.33%
51,200 $2.08 Million
Q4 2016

May 14, 2018

BUY
N/A
46,405
46,405 $1.87 Million

Others Institutions Holding HAE

About HAEMONETICS CORP


  • Ticker HAE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 51,316,500
  • Market Cap $4.36B
  • Description
  • Haemonetics Corporation, a healthcare company, provides medical products and solutions. It operates through three segments: Plasma, Blood Center, and Hospital. The company offers automated plasma collection devices, related disposables, and software, including NexSys PCS and PCS2 plasmapheresis equipment and related disposables and intravenous s...
More about HAE
Track This Portfolio

Track Keybank National Association Portfolio

Follow Keybank National Association and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Keybank National Association, based on Form 13F filings with the SEC.

News

Stay updated on Keybank National Association with notifications on news.